| Dr Miranda Eiseman, DO | |
|
310 15th Ave E, Seattle, WA 98112-5103 | |
| (206) 326-3000 | |
| Not Available |
| Full Name | Dr Miranda Eiseman |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 310 15th Ave E, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144669433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5101020669 (Michigan) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Warmer weather brings joy to most people but misery for hay fever (pollen allergy) sufferers. For 50 million people in the United States alone, spring means sneezing spasms, itchy and watery eyes, and congestion at an annual cost of 18 billion.
Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of exposure to toxins in the vapour, according to new research funded by Cancer Research UK and published in Addiction today.
Ajinomoto AminoScience LLC (AAS) today announced that it has confirmed GRAS (Generally Recognized As Safe) status of its AjiGRAS-Leucine, meeting the safety standards demanded by the US Food and Drug Administration (FDA). As the only formulation of Leucine currently with FDA acknowledged GRAS status, Ajinomoto's AjiGRAS-Leucine is the first amino acid to be allowed as an ingredient for use in conventional foods like non-milk and milk based meal replacements, sports and isotonic beverages, vitamin enhanced waters, and meal replacement bars, at levels of 0.5 to 3 grams per serving.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Miranda Eiseman, DO 330 Barclay Ave Ne, Suite 102, Grand Rapids, MI 49503-2556 Ph: (616) 391-2160 | Dr Miranda Eiseman, DO 310 15th Ave E, Seattle, WA 98112-5103 Ph: (206) 326-3000 |
News Archive
Warmer weather brings joy to most people but misery for hay fever (pollen allergy) sufferers. For 50 million people in the United States alone, spring means sneezing spasms, itchy and watery eyes, and congestion at an annual cost of 18 billion.
Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of exposure to toxins in the vapour, according to new research funded by Cancer Research UK and published in Addiction today.
Ajinomoto AminoScience LLC (AAS) today announced that it has confirmed GRAS (Generally Recognized As Safe) status of its AjiGRAS-Leucine, meeting the safety standards demanded by the US Food and Drug Administration (FDA). As the only formulation of Leucine currently with FDA acknowledged GRAS status, Ajinomoto's AjiGRAS-Leucine is the first amino acid to be allowed as an ingredient for use in conventional foods like non-milk and milk based meal replacements, sports and isotonic beverages, vitamin enhanced waters, and meal replacement bars, at levels of 0.5 to 3 grams per serving.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
› Verified 6 days ago
Dr. Jaime Marie Michaelson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 310 15th Ave E, Seattle, WA 98112 Phone: 206-326-3000 | |
Alisa Beth Kachikis, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, 3rd Floor Sw 350, Seattle, WA 98195 Phone: 206-598-4070 | |
Karen L. Bohmke, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1101 Madison St, #1150, Seattle, WA 98104 Phone: 206-386-3400 | |
Lisa S. Callegari, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-520-5000 | |
Anne-marie Elizabeth Amies Oelschlager, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Uwmc-roosevelt, 4245 Roosevelt Way Ne, Seattle, WA 98105 Phone: 206-598-5500 | |
Shirley Andrews, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1560 N 115th St Ste 212, Seattle, WA 98133 Phone: 206-363-2800 Fax: 206-363-2811 | |
Lyndsey Summer Benson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Box 356460, Seattle, WA 98195 Phone: 610-202-4028 |